NADH-cytochrome b5 reductase 3 promotes colonization and metastasis formation and is a prognostic marker of disease-free and overall survival in estrogen receptor-negative breast cancer

Molecular and Cellular Proteomics

Volumn 14, Issue 11, 2015, Pages 2988-2999

  Lund, Rikke R ^a,e   Leth Larsen, Rikke ^a   Di Caterino, Tina ^b   Terp, Mikkel G ^a   Nissen, Jeanette ^a   Lænkholm, Anne Vibeke ^c   Jensen, Ole N ^a   Ditzel, Henrik J ^a,d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e Alphalyse A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B5 REDUCTASE; CYTOCHROME B5 REDUCTASE 3; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE A; NIEMANN PICK C1 PROTEIN; NUCLEOLAR RNA HELICASE 2; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYB5R3 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOENZYME; LACTATE DEHYDROGENASE 5; MEMBRANE PROTEIN; NERVE GROWTH FACTOR RECEPTOR; NPC1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CIRCULATING TUMOR CELL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CANCER TRANSPLANTATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; SCID MOUSE; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CYTOCHROME-B(5) REDUCTASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOENZYMES; L-LACTATE DEHYDROGENASE; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, NERVE GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84946080481     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.050385     Document Type: Article

References (41)

1. Cairns, R. A., Khokha, R., and Hill, R. P. (2003) Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr. Mol. Med. 3, 659-671
2. Steeg, P. S., and Theodorescu, D. (2008) Metastasis: A therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5, 206-219
3. Brosh, R., and Rotter, V. (2009) When mutants gain new powers: News from the mutant p53 field. Nat. Rev. Cancer 9, 701-713
4. Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., and Lane, D. P. (2009) Awakening guardian angels: Drugging the p53 pathway. Nat. Rev. Cancer 9, 862-873
5. Jiang, P., Enomoto, A., and Takahashi, M. (2009) Cell biology of the movement of breast cancer cells: Intracellular signalling and the actin cytoskeleton. Cancer Lett. 284, 122-130
6. Parsons, J. T., Horwitz, A. R., and Schwartz, M. A. (2010) Cell adhesion: Integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 11, 633-643
7. Lurje, G., and Lenz, H. J. (2009) EGFR signaling and drug discovery. Oncology 77, 400-410
8. Urquidi, V., Sloan, D., Kawai, K., Agarwal, D., Woodman, A. C., Tarin, D., and Goodison, S. (2002) Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8, 61-74
9. Goodison, S., Kawai, K., Hihara, J., Jiang, P., Yang, M., Urquidi, V., Hoffman, R. M., and Tarin, D. (2003) Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. 9, 3808-3814
10. Schwirzke, M., Evtimova, V., Burtscher, H., Jarsch, M., Tarin, D., and Weidle, U. H. (2001) Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. Anticancer Res. 21, 1771-1776
11. Euer, N., Schwirzke, M., Evtimova, V., Burtscher, H., Jarsch, M., Tarin, D., and Weidle, U. H. (2002) Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 22, 733-740
12. Goodison, S., Yuan, J., Sloan, D., Kim, R., Li, C., Popescu, N. C., and Urquidi, V. (2005) The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 65, 6042-6053
13. Thomsen, K. G., Terp, M. G., Lund, R. R., Sokilde, R., Elias, D., Bak, M., Litman, T., Beck, H. C., Lyng, M. B., and Ditzel, H. J. (2015) miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations. Oncotarget (Epub ahead of print)
14. Lund, R., Leth-Larsen, R., Jensen, O. N., and Ditzel, H. J. (2009) Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. J. Proteome Res. 8, 3078-3090
15. Leth-Larsen, R., Lund, R., Hansen, H. V., Laenkholm, A. V., Tarin, D., Jensen, O. N., and Ditzel, H. J. (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell. Proteomics 8, 1436-1449
16. Karhemo, P. R., Ravela, S., Laakso, M., Ritamo, I., Tatti, O., Mäkinen, S., Goodison, S., Stenman, U. H., Hölttä, E., Hautaniemi, S., Valmu, L., Lehti, K., and Laakkonen, P. (2012) An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. J. Proteomics 77, 87-100
17. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M., and Goodison, S. (2007) Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry. Cancer Genomics Proteomics 4, 329-339
18. Kreunin, P., Urquidi, V., Lubman, D. M., and Goodison, S. (2004) Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique. Proteomics 4, 2754-2765
19. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M., and Goodison, S. (2007) Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 7, 299-312
20. Xie, X., Feng, S., Vuong, H., Liu, Y., Goodison, S., and Lubman, D. M. (2010) A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach. Electrophoresis 31, 1842-1852
21. Rappsilber, J., Ishihama, Y., and Mann, M. (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670
22. Callesen, A. K., Mohammed, S., Bunkenborg, J., Kruse, T. A., Cold, S., Mogensen, O., Christensen, R., Vach, W., Jørgensen, P. E., and Jensen, O. N. (2005) Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 19, 1578-1586
23. Vizcaíno, J. A., Deutsch, E. W., Wang, R., Csordas, A., Reisinger, F., Ríos, D., Dianes, J. A., Sun, Z., Farrah, T., Bandeira, N., Binz, P. A., Xenarios, I., Eisenacher, M., Mayer, G., Gatto, L., Campos, A., Chalkley, R. J., Kraus, H. J., Albar, J. P., Martinez-Bartolomé, S., Apweiler, R., Omenn, G. S., Martens, L., Jones, A. R., and Hermjakob, H. (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226
24. Schandorff, S., Olsen, J. V., Bunkenborg, J., Blagoev, B., Zhang, Y., Andersen, J. S., and Mann, M. (2007) A mass spectrometry-friendly database for cSNP identification. Nat. Methods 4, 465-466
25. Elias, J. E., Gibbons, F. D., King, O. D., Roth, F. P., and Gygi, S. P. (2004) Intensity-based protein identification by machine learning from a library of tandem mass spectra. Nat. Biotechnol. 22, 214-219
26. Mortensen, P., Gouw, J. W., Olsen, J. V., Ong, S. E., Rigbolt, K. T., Bunkenborg, J., Cox, J., Foster, L. J., Heck, A. J., Blagoev, B., Andersen, J. S., and Mann, M. (2010) MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J. Proteome Res. 9, 393-403
27. Bloom, H. J., and Richardson, W. W. (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 11, 359-377
28. Punt, C. J., Buyse, M., Köhne, C. H., Hohenberger, P., Labianca, R., Schmoll, H. J., Påhlman, L., Sobrero, A., and Douillard, J. Y. (2007) Endpoints in adjuvant treatment trials: A systematic review of the literature in colon cancer and proposed definitions for future trials. J. Nat. Cancer Inst. 99, 998-1003
29. Lundholt, B. K., Briand, P., and Lykkesfeldt, A. E. (2001) Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways. Breast Cancer Res. Treat. 67, 199-214
30. Elahian, F., Sepehrizadeh, Z., Moghimi, B., and Mirzaei, S. A. (2014) Human cytochrome b5 reductase: structure, function, and potential applications. Crit. Rev. Biotechnol. 34, 134-143
31. De Cabo, R., Siendones, E., Minor, R., and Navas, P. (2010) CYB5R3: A key player in aerobic metabolism and aging? Aging 2, 63-68
32. Siendones, E., SantaCruz-Calvo, S., Martín-Montalvo, A., Cascajo, M. V., Ariza, J., López-Lluch, G., Villalba, J. M., Acquaviva-Bourdain, C., Roze, E., Bernier, M., De Cabo, R., and Navas, P. (2014) Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2. Antioxidants Redox Signaling 21, 1708-1725
33. Cailleau, R., Olivé, M., and Cruciger, Q. V. (1978) Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14, 911-915
34. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van De Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227-235
35. Sellappan, S., Grijalva, R., Zhou, X., Yang, W., Eli, M. B., Mills, G. B., and Yu, D. (2004) Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line. Cancer Res. 64, 3479-3485
36. Montel, V., Suzuki, M., Galloy, C., Mose, E. S., and Tarin, D. (2009) Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation 78, 283-291
37. Price, J. E., and Zhang, R. D. (1990) Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev. 8, 285-297
38. Victor, R., Chauzy, C., Girard, N., Gioanni, J., D'Anjou, J., Stora De Novion, H., and Delpech, B. (1999) Human breast-cancer metastasis formation in a nude-mouse model: Studies of hyaluronidase, hyaluronan and hyaluronanbinding sites in metastatic cells. Int. J. Cancer 82, 77-83
39. Shah, S. N., Cope, L., Poh, W., Belton, A., Roy, S., Talbot, C. C., Jr., Sukumar, S., Huso, D. L., and Resar, L. M. (2013) HMGA1: A master regulator of tumor progression in triple-negative breast cancer cells. PLoS ONE 8, e63419
40. Quail, D. F., Zhang, G., Walsh, L. A., Siegers, G. M., Dieters-Castator, D. Z., Findlay, S. D., Broughton, H., Putman, D. M., Hess, D. A., and Postovit, L. M. (2012) Embryonic morphogen nodal promotes breast cancer growth and progression. PLoS ONE 7, e48237
41. Mukhopadhyay, R., Theriault, R. L., and Price, J. E. (1999) Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin. Exp. Metastasis 17, 325-332